Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $0.40 B
According to Dynavax Technologies 's latest financial reports the company's total liabilities are $0.40 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.40 B | -50.44% |
| 2021-12-31 | $0.81 B | 177.3% |
| 2020-12-31 | $0.29 B | 8.79% |
| 2019-12-31 | $0.27 B | 83.18% |
| 2018-12-31 | $0.14 B | 668.45% |
| 2017-12-31 | $19.23 M | -6.07% |
| 2016-12-31 | $20.47 M | -30.71% |
| 2015-12-31 | $29.55 M | -21.83% |
| 2014-12-31 | $37.8 M | 106.29% |
| 2013-12-31 | $18.32 M | -26.47% |
| 2012-12-31 | $24.92 M | -27.16% |
| 2011-12-31 | $34.22 M | 6.48% |
| 2010-12-31 | $32.13 M | -27.11% |
| 2009-12-31 | $44.09 M | -40.79% |
| 2008-12-31 | $74.46 M | -8.42% |
| 2007-12-31 | $81.31 M | 241.41% |
| 2006-12-31 | $23.81 M | 315.67% |
| 2005-12-31 | $5.73 M | -58.39% |
| 2004-12-31 | $13.77 M | -84.49% |
| 2003-12-31 | $88.78 M | 1.06% |
| 2002-12-31 | $87.84 M | 77.35% |
| 2001-12-31 | $49.53 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $101.28 B | 24,836.36% | 🇺🇸 USA |
 Amgen AMGN | $83.37 B | 20,425.37% | 🇺🇸 USA |
 Biogen BIIB | $10.81 B | 2,561.66% | 🇺🇸 USA |
 Gilead Sciences GILD | $40.93 B | 9,978.29% | 🇺🇸 USA |
 Merck MRK | $63.10 B | 15,435.09% | 🇺🇸 USA |
 AstraZeneca AZN | $60.87 B | 14,887.08% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.57 B | 14,319.85% | 🇬🇧 UK |
 Agenus
AGEN | $0.46 B | 15.33% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.31 B | 8,594.21% | 🇮🇱 Israel |